Garbose Dosage & Drug Information

Indications/Uses

Adjunct to diet in patients w/ DM.

Dosage/Direction for Use

Initially 50 mg tds, may be increased to 200 mg tds. Ave dose: 300 mg daily.

Administration

Should be taken with food: Swallow whole w/ a little liqd directly before meals or chew w/ the 1st few mouthfuls of meals.

Contraindications

Chronic intestinal disorders, inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, major hernia, Roemheld's syndrome. Hepatic impairment, severe renal impairment (CrCl <25 mL/min). Pregnancy & lactation. Childn <18 yr.

Special Precautions

Monitor hepatic enzymes from 1st 6-12 mth of therapy.

Adverse Reactions

Flatulence, diarrhea, GI pain.

View ADR Reporting Link

Drug Interactions

Concomitant use w/ sucrose, hypoglycaemics, intestinal absorbents & digestive enzymes, neomycin, cholestyramine, digoxin.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BF01 - acarbose ; Belongs to the class of alpha glucosidase inhibitors. Used in the treatment of diabetes.

Regulatory Classification

C

Presentation/Packing

Form

Garbose tab 100 mg

Packing/Price

10 × 10's

Form

Garbose tab 50 mg

Packing/Price

10 × 10's

Garbose

acarbose

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries